Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CV Sciences (CVSI) Stock Price & Analysis

CVSI Stock Chart & Stats

$0.01-$0.00(-7.65%)
At close: 10:29 AM EST
$0.01$0.015$0.02$0.0253 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.10
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
550.87K
Market Cap
$1.92M
Enterprise Value
$5.97M
Total Cash (Recent Filing)
$266.00K
Total Debt (Recent Filing)
$1.25M
Price to Earnings (P/E)
―
Beta
0.63
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Stable Gross Margin

A roughly 49% gross margin has remained relatively steady in TTM and 2025, showing product economics have not deteriorated despite weaker sales. Preserving gross profit per dollar can support recovery if distribution and demand improve.

Product Innovation

Products launched since January 2023 generated 44% of Q2 net revenue, while the PlusHLTH portfolio and dedicated e-commerce platform broaden the offering. This indicates active development and creates avenues for repeatable growth beyond the legacy range.

Cost Discipline

Operating expenses fell 11.3% year over year to $1.7 million in Q2, demonstrating the company can adjust its cost base as revenue weakens. Continued discipline could slow losses and improve operating leverage if new products gain traction.

Bears Say

Revenue Contraction

TTM revenue fell about 27.1% year over year and Q2 revenue declined 17.5%, showing contraction across periods rather than a single-quarter setback. A shrinking top line reduces scale benefits and makes fixed costs harder to absorb.

Persistent Losses

The company remains unprofitable, with a TTM net margin of about -15.7% and negative operating profitability; Q2 operating loss widened to $0.3 million. Persistent losses consume equity and constrain internally funded investment.

Negative Cash Generation

TTM operating cash flow was about -$0.49 million and free cash flow about -$0.52 million, continuing the outflow pattern from 2024–2025. Ongoing cash burn means growth and obligations may require external capital if profitability does not recover.

CV Sciences News

CVSI FAQ

What was CV Sciences’s price range in the past 12 months?
CV Sciences lowest stock price was $0.01 and its highest was $0.10 in the past 12 months.
What is CV Sciences’s market cap?
CV Sciences’s market cap is $1.92M.
When is CV Sciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CV Sciences’s earnings last quarter?
CV Sciences released its earnings results on Aug 17, 2026. The company reported -$0.004 earnings per share for the quarter.
Is CV Sciences overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does CV Sciences pay dividends?
CV Sciences does not currently pay dividends.
What is CV Sciences’s EPS estimate?
CV Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CV Sciences have?
CV Sciences has 225,829,130 shares outstanding.
What happened to CV Sciences’s price movement after its last earnings report?
CV Sciences reported an EPS of -$0.004 in its last earnings report. Following the earnings report the stock price went down -24%.
Which hedge fund is a major shareholder of CV Sciences?
Currently, no hedge funds are holding shares in CVSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology